期刊
ONCOTARGET
卷 6, 期 12, 页码 10016-10029出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.3540
关键词
Stat3; VEGFR2; Stat3 inhibitor; brain metastasis; brain endothelial cells
资金
- U.S. Department of Defense Breast Cancer Research Program Center of Excellence Award [W81XWH-06-2-0033]
- NCI [P50CA127001]
- NSC [102-2320-B-010-032]
Brain metastasis is a major cause of morbidity and mortality in patients with breast cancer. Our previous studies indicated that Stat3 plays an important role in brain metastasis. Here, we present evidence that Stat3 functions at the level of the microenvironment of brain metastases. Stat3 controlled constitutive and inducible VEGFR2 expression in tumor-associated brain endothelial cells. Furthermore, inhibition of Stat3 by WP1066 decreased the incidence of brain metastases and increased survival in a preclinical model of breast cancer brain metastasis. WP1066 inhibited Stat3 activation in tumor-associated endothelial cells, reducing their infiltration and angiogenesis. WP1066 also inhibited breast cancer cell invasion. Our results indicate that WP1066 can inhibit tumor angiogenesis and brain metastasis mediated by Stat3 in endothelial and tumor cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据